Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Pot

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Revue Medicale Suisse|May 3, 2023
[Cognitive impairment in multiple sclerosis: when to think about it?]Matthieu Perrenoud, Laurène Blosch, Renaud Du Pasquier, et al.
Revue Medicale Suisse|May 7, 2020
Awa Traore, Caroline Pot, Christophe Bonvin, et al.
Journal of Lipid Research|December 17, 2023
25-Hydroxycholesterol in health and diseasesCindy Nguyen, Julien Saint-Pol, Shiraz Dib, et al.
Multiple Sclerosis and Related Disorders|April 10, 2021
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatmentVasiliki Pantazou, Caroline Pot, Renaud Du Pasquier, et al.
Cell|March 15, 2024
Closing the scissor-shaped curve: Strategies to promote gender equality in academiaJohanna A Joyce, Slavica Masina, Liliane Michalik, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational StudyCédric O Renaud, Panos G Ziros, Amandine Mathias, et al.
Revue Medicale Suisse|April 26, 2024
[Anti-MOG associated disease]Julien Lerusse, Marjolaine Uginet, Marie Théaudin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2015
IL-27 Induces Th17 Differentiation in the Absence of STAT1 SignalingAnneli Peters, Kevin D Fowler, Fanny Chalmin, et al.
Revue Medicale Suisse|April 26, 2024
[Treatments for multiple sclerosis: update]Marjolaine Uginet, Lucie Lefeuvre, Julien Lerusse, et al.
Archives of Neurology|September 13, 2006
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathyCaroline Pot, Carlo Chizzolini, Natalia Vokatch, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Revue Medicale Suisse|May 3, 2023
[Cognitive impairment in multiple sclerosis: when to think about it?]Matthieu Perrenoud, Laurène Blosch, Renaud Du Pasquier, et al.
Revue Medicale Suisse|May 7, 2020
Awa Traore, Caroline Pot, Christophe Bonvin, et al.
Journal of Lipid Research|December 17, 2023
25-Hydroxycholesterol in health and diseasesCindy Nguyen, Julien Saint-Pol, Shiraz Dib, et al.
Multiple Sclerosis and Related Disorders|April 10, 2021
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatmentVasiliki Pantazou, Caroline Pot, Renaud Du Pasquier, et al.
Cell|March 15, 2024
Closing the scissor-shaped curve: Strategies to promote gender equality in academiaJohanna A Joyce, Slavica Masina, Liliane Michalik, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational StudyCédric O Renaud, Panos G Ziros, Amandine Mathias, et al.
Revue Medicale Suisse|April 26, 2024
[Anti-MOG associated disease]Julien Lerusse, Marjolaine Uginet, Marie Théaudin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2015
IL-27 Induces Th17 Differentiation in the Absence of STAT1 SignalingAnneli Peters, Kevin D Fowler, Fanny Chalmin, et al.
Revue Medicale Suisse|April 26, 2024
[Treatments for multiple sclerosis: update]Marjolaine Uginet, Lucie Lefeuvre, Julien Lerusse, et al.
Archives of Neurology|September 13, 2006
Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathyCaroline Pot, Carlo Chizzolini, Natalia Vokatch, et al.
Pageof 11